Recent advances in the role of interleukin-6 in health and disease

Curr Opin Pharmacol. 2020 Jun:52:47-51. doi: 10.1016/j.coph.2020.04.010. Epub 2020 Jun 18.

Abstract

Interleukin-6 (IL-6) is a pleotropic cytokine, and in this review, we highlight recent studies focusing on the role of IL-6 in health and disease. IL-6 is known as an exercise-inducible myokine, and in rodents it was identified that a lactate-dependent increase in protease activity mediates IL-6 release from skeletal muscle, which acts in both an autocrine and paracrine roles. In humans, a series of publications observed that blocking IL-6 during exercise training prevented beneficial adaptations, such as reductions in visceral and epicardial fat mass. Independent of exercise, IL-6 impacts postprandial physiology, as demonstrated by a slowing of gastric emptying rate and improving glucose homeostasis. Finally, an engineered cytokine harnessing the biology of IL-6, termed IC7Fc, was found to have beneficial impacts on numerous health outcomes. Together, these recent advances indicate that IL-6 has a multifaceted, and perhaps beneficial, role in health and disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Exercise / physiology*
  • Glucose / metabolism
  • Health Status*
  • Humans
  • Interleukin-6 / metabolism*
  • Muscle, Skeletal / metabolism*
  • Muscle, Skeletal / pathology
  • Musculoskeletal Diseases / metabolism*
  • Musculoskeletal Diseases / pathology
  • Receptors, Interleukin-6 / metabolism

Substances

  • Interleukin-6
  • Receptors, Interleukin-6
  • Glucose